港股異動 | 中天國際(2379.HK)暴漲1.7倍創近兩年半新高 與水發民生訂立戰略合作框架協議
格隆匯8月5日丨中天國際(2379.HK)今日盤中高見1.3港元,創2018年2月15日以來近兩年半新高,現報1.09港元,暴漲172.5%,暫成交2129萬港元,最新總市值4.5億港元。中天國際昨日盤後公佈,於7月31日,公司全資附屬公司青島中天企業發展有限公司與水發民生產業投資集團有限公司訂立與物業開發項目合作有關的戰略合作框架協議。根據框架協議,青島中天及水發民生擬於產城開發及其他物業開發項目開展合作。董事會認為,由於訂立框架協議令訂約雙方可利用各自優勢、資源及專長以建立穩定互惠戰略關係以開發產城相關項目,其符合公司及其股東整體利益。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.